Alaunos Therapeutics Ownership | Who Owns Alaunos Therapeutics?


OverviewForecastRevenueFinancialsChart

Alaunos Therapeutics Ownership Summary


Alaunos Therapeutics is owned by 1.26% institutional investors, 3.78% insiders, and 94.96% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 1.27% of TCRT shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 1.56% of its assets in Alaunos Therapeutics shares.

TCRT Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAlaunos Therapeutics1.26%3.78%94.96%
SectorHealthcare Stocks 42.53%10.81%46.67%
IndustryBiotech Stocks 45.24%10.75%44.01%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de21.35K1.27%$51.46K
Vanguard group20.97K1.25%$51.17K
Geode capital management15.79K0.94%$38.54K
Morgan stanley1.68K0.10%$4.06K
Tower research capital llc (trc)1.63K0.10%$3.94K
Ubs group1.53K0.09%$3.69K
Advisor group1.17K0.07%$2.81K
Cibc private wealth group300.000.02%$1.46K
Wells fargo & company/mn183.000.01%$441.00
Ronald blue trust135.000.01%$325.00

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Tower research capital llc (trc)1.63K0.00%$3.94K
Eversource wealth advisors---
Thurston, springer, miller, herd & titak---
Federation des caisses desjardins du quebec70.00-$169.00
Nbc securities20.00-$48.00
Barclays50.00-$121.00
Steward partners investment advisory92.00-$222.00
Advisor group1.17K-$2.81K
Truvestments capital1.00-$2.00
Geode capital management15.79K-$38.54K

Top Buyers

HolderShares% AssetsChange
Tower research capital llc (trc)1.63K0.00%660.00
Advisor group1.17K-470.00
Ronald blue trust135.00-135.00
Barclays50.00-50.00
Nbc securities20.00-20.00

Top Sellers

HolderShares% AssetsChange
Ubs group1.53K--5.28K
Steward partners investment advisory92.00--1.01K
Group one trading---300.00
Geode capital management15.79K--155.00
Morgan stanley1.68K--114.00

New Positions

HolderShares% AssetsChangeValue
Ronald blue trust135.00-135.00$325.00
Barclays50.00-50.00$121.00
Nbc securities20.00-20.00$48.00
Wealthspire advisors1.00-1.00$3.00

Sold Out

HolderChange
Tidemark-2.00
Jpmorgan chase-3.00
Investment management corp /va/ /adv-6.00
Psi advisors-6.00
West paces advisors-10.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20255-80.77%21,173-70.16%16.43%1-83.33%--100.00%
Jun 30, 20256-76.92%21,065-70.09%16.80%1-83.33%--100.00%
Mar 31, 202526-10.34%70,434-2.20%421.75%6-25.00%5-58.33%
Dec 31, 2024293.57%72,017-62.50%43.13%860.00%12-47.83%
Sep 30, 202428-40.43%192,061-92.10%115.21%5-61.54%23109.09%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF24.91K1.56%-15.49K
Vanguard Total Stock Mkt Idx Inv17.35K1.08%-7.03K
Vanguard Institutional Extnd Mkt Idx Tr14.06K0.71%-6.41K
Fidelity Extended Market Index9.14K0.41%-64.00
BlackRock Extended Equity Market K2.98K0.19%-2.00
Extended Equity Market Fund K2.89K0.18%-58.00
Fidelity Series Total Market Index2.47K0.11%-1.57K
Fidelity Total Market Index2.38K0.11%-
NT Ext Equity Mkt Idx Fd - L1.36K0.08%-
Northern Trust Extended Eq Market Idx1.36K0.08%-

Recent Insider Transactions


DateNameRoleActivityValue
Jun 24, 2025Vieser Jaime-Buy$1.12K
Jun 24, 2025Postma Robert W-Buy$2.69K
Apr 11, 2025Postma Robert W-Buy$1.38K
Dec 31, 2024Vieser Jaime-Sell$4.39K
Dec 31, 2024Vieser Jaime-Sell$1.64K

Insider Transactions Trends


DateBuySell
2025 Q3--
2025 Q23-
2025 Q1--
2024 Q4-2
2024 Q3--

TCRT Ownership FAQ


Who Owns Alaunos Therapeutics?

Alaunos Therapeutics shareholders are primarily institutional investors at 1.26%, followed by 3.78% insiders and 94.96% retail investors. The average institutional ownership in Alaunos Therapeutics's industry, Biotech Stocks , is 45.24%, which Alaunos Therapeutics falls below.

Who owns the most shares of Alaunos Therapeutics?

Alaunos Therapeutics’s largest shareholders are Blackrock funding, inc. /de (21.35K shares, 1.27%), Vanguard group (20.97K shares, 1.25%), and Geode capital management (15.79K shares, 0.94%). Together, they hold 3.47% of Alaunos Therapeutics’s total shares outstanding.

Does Blackrock own Alaunos Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Alaunos Therapeutics.

Who is Alaunos Therapeutics’s biggest shareholder by percentage of total assets invested?

Tower research capital llc (trc) is Alaunos Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.00% of its assets in 1.63K Alaunos Therapeutics shares, valued at 3.94K$.

Who is the top mutual fund holder of Alaunos Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Alaunos Therapeutics shares, with 1.56% of its total shares outstanding invested in 24.91K Alaunos Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools